Current and emerging therapeutic approaches to pulmonary hypertension

Pulmonary arterial hypertension (PAH) is a progressive and fatal lung disease of multifactorial etiology. Most of the available drugs and FDA-approved therapies for treating pulmonary hypertension attempt to overcome the imbalance between vasoactive and vasodilator mediators, and restore the endothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Bisserier, Malik, Pradhan, Natasha, Hadri, Lahouaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389678/
https://www.ncbi.nlm.nih.gov/pubmed/32706206
http://dx.doi.org/10.31083/j.rcm.2020.02.597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389678/
https://www.ncbi.nlm.nih.gov/pubmed/32706206
http://dx.doi.org/10.31083/j.rcm.2020.02.597

Ejemplares similares